Randomized phase 3 trial of irinotecan (CPT-11) + 5FU/folinic acid (FA) vs CDDP + 5FU in 1st-line advanced gastric cancer patients
Bildiriler > Özet Bildiri
Yazarlar: M. Dank, J. Zaluski, C. Barone, V. Valvere, C. Peschel, M. Wenczl, Erdem GÖKER, M.-L. Risse, L. Awad, R. Bugat
Journal of Clinical Oncology, , , Uluslararası, Özet Bildiri, Wos, cilt 23, ss 4003-4003
DOI: 10.1200/jco.2005.23.16_suppl.4003
Özet
4003